EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/474673
EW CATARACT 79 March 2015 cataract surgery and we reach our refractive goal, we will plan for the RLE within a week or so of the first eye surgery." We then discuss the various options of bilateral emmetropia, blended vision with monofocal IOL, or multifocal lens bilaterally. "This choice gives you relief from the poor vision the cataract has caused and also gives you a re- fractive goal for less dependence on glasses and contacts into the future. In my experience, once you see how easily the cataract surgery can go, you won't put up with dependence on the contact for long and will be begging for surgery in the second eye if we aim for emmetropia in the first. Given the risks of surgery [I discuss increased risk of RD due to high myopia; if there is a unilateral cataract due to disease or injury, the discussion has already taken place], you need to be the one to decide if you wish to postpone any risk to the sound eye and restore your previous condition in glasses or choose one of the other options." Thomas A. Oetting, MD Professor of ophthalmology, University of Iowa, Iowa City I would tell patients: "Now that we have decided to do cataract surgery on just one of your eyes, we have another issue to discuss. We have to decide what power intraocular lens to place. One option is to simply leave you nearsighted like you are now, making it so the operative eye after surgery matches your unoper- ated eye's need for glasses. This will make wearing glasses easy because the strength in both of the spectacle lenses will be about the same." I pause to make sure they under- stand. I continue, "The other op- tion is to place an intraocular lens during surgery that will allow you to see well far away without spec- tacles. This will be a nice long-term solution as eventually you will need cataract surgery in the other eye, and then we could make it so you don't need glasses to see far away with either eye. However, during the period of time between surgeries we would have an important issue with this option. If we place the intraocular lens so you don't need any spectacle power to see far, you will have one eye that still needs a lot of spectacle power and the other Be Compromise-Free! Other cataract laser companies have me bundled up without the freedom to choose what's best for my patients. Visit us at ASCRS booth #1750 and let us help you become compromise-free with LENSAR www.LENSAR.com The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, laser phacofragmentation, and the creation of full and partial thickness single-plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. Laser Capsulotomy, laser phacofragmentation and/or corneal incisions surgery is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greater than that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm or greater than 7 mm, who have existing corneal implants, who have previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have conditions that would cause inadequate clearance between the intended capsulotomy cut and the corneal endothelium, such as: hypotony, uncontrolled glaucoma, who have corneal disease or pathology that precludes transmission of light at the laser wavelength or causes distortion of laser light, such as: corneal opacities, residual, recurrent, active ocular or uncontrolled eyelid disease or any corneal abnormalities (including endothelial dystrophy, guttata, recurrent corneal erosion, etc.) in the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a history of severe dry eye that has not responded to therapy, a history of herpes zoster or herpes simplex keratitis. Potential contraindications are not limited to those included in the list. WARNING: The safety and effectiveness of this laser have NOT been established in patients with diabetic retinopathy, a history of treated glaucoma, or prior intraocular surgery. © 2015 LENSAR, Inc. All rights reserved. LENSAR and the LENSAR logo are registered trademarks and Augmented Reality is a trademark of LENSAR, Inc. 50-00102-000 Rev A 02/15 continued on page 80